diseases causeing hilar and mediastinal lymphadenopathy (malignancy, sarcodosis, etc)
Conditions
Interventions
None listed
Sponsors
Oita university faculty of medicine, Department of respiratory medicine and infectious diseases
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients who had undergone EBUS-TBNA for the diagnosis of mediastinal and/or hilar lymphadenopathy
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| diagnostic yields | — |
Secondary
| Measure | Time frame |
|---|---|
| the length of the examination for EBUS-TBNA, the number of needle aspirations per patient, complications, and additional examinations needed | — |
Countries
Japan
Contacts
Public ContactMari Yamasue
Oita university faculty of medicine Department of respiratory medicine and infectious diseases
Outcome results
None listed